. 2011 May 8;79(3):429–447. doi: 10.3797/scipharm.1103-16
© El-Moghazy et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig.2.
CDK2 inhibitors which were used for building the pharmacophore model (2)